Boston-based Beacon Capital Partners offloaded a Denver office building to Kore Investments six years after purchasing it.
Enveda Biosciences was recently cleared to begin clinical trials of its drug candidate for the treatment of inflammatory bowel disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback